32 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

D2.314 - Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report

Thumbnail

D2.309 - Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience

Thumbnail

D2.310 - Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis

Thumbnail

D2.311 - Real World Web Survey on the Burden of Urticaria

Thumbnail

D2.312 - Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis

Thumbnail

D2.313 - Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks

Thumbnail

D2.315 - Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases

Thumbnail

D2.316 - The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis

Thumbnail

D2.317 - The role of sirtuin 2 (SIRT2) in atopic dermatitis

Thumbnail

D2.318 - Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients